Abstract
A series of substituted dihydropyrimidin-2(1H)-thione derivatives (1–8) have been synthesized and docked against enzymes human topoisomerase II alpha (4FM9) and Helicobacter pylori urease (1E9Y) for binding mode validation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have